The goal of this activity is for learners to be better able to differentiate between available bispecific antibodies used in the treatment of R/R DLBCL and integrate evidence-based treatment strategies.
- Provider:Medscape, LLC
- Activity Link: https://www.medscape.org/viewarticle/1001209
- Start Date: 2024-06-18 05:00:00
- End Date: 2024-06-18 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - MOC Credit Details: ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Genmab US, Inc. - Amount: 84327.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Hematology, Medical Oncology
Subscribe
Login
0 Comments
Oldest